Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.
By G. Grasselli, A. Pesenti, M. Cecconi. Journal of the American Medical Association (JAMA), 2020
2,038 citations recorded by the source corpus.
On February 20, 2020, a patient in his 30s admitted to the intensive care unit (ICU) in Codogno Hospital (Lodi, Lombardy, Italy) tested positive for a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). He had a history of atypical pneumonia that was not responding to treatment, but he was not considered at risk for COVID-19 infection.1 The positive result was immediately reported to the Lombardy health care system and governmental offices. During the next 24 hours, the number of reported positive cases increased to 36. This situation was considered a serious development for several reasons: the patient (“patient 1”) was healthy and young; in less than 24 hours, 36 additional cases were identified, without links to patient 1 or previously identified positive cases already in the country; it was not possible to identify with certainty the source of transmission to patient 1 at the time; and, because patient 1 was in the ICU and there were already 36 cases by day 2, chances were that a cluster of unknown magnitude was present and additional spread was likely. On February 21, an emergency task force was formed by the Government of Lombardy and local health authorities to lead the response to the outbreak. This Viewpoint provides a summary of the response of the COVID-19 Lombardy ICU network and a forecast of estimated ICU demand over the coming weeks (projected to March 20, 2020).
Subfields: Emergency Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/708112dbc15477f10ca28d9b6dda5de0b14cb42e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- How simulation modelling can help reduce the impact of COVID-19 (2020, background): “Italy for example, has been experiencing extreme stress on its intensive care system (Grasselli et al., 2020; Remuzzi & Remuzzi, 2020), with patients being unable to access critical care beds and dying in hospital corridors while waiting for beds to be released.”
- Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations (2020, neutral): “6,9 The sustainability of depending on a few centres, or scarcity thereof, even as the outbreak worsens must be considered.”
- Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study (2020, neutral): “[8] [9] [10] [11] [12] Consequently, there will be an ongoing need for frontline healthcare workers (HCW) in patient-facing roles.”
- COVID-19 identification in chest X-ray images on flat and hierarchical classification scenarios (2020, neutral): “The impact in the healthcare system is also high due to the amount of people that needs ICU admission and mechanical ventilators for long periods [5].”
- COVID-19 Future Forecasting Using Supervised Machine Learning Models (2020, neutral): “In particular, the study [7] is focused on live forecasting of COVID-19 confirmed cases and study [8] is also focused on the forecast of COVID-19 outbreak and early response.”
- An empirical estimate of the infection fatality rate of COVID-19 from the first Italian outbreak (2020, background): “While widespread randomized antibody testing hasn't yet been conducted in this area, 30% of a sample of blood donors from all ten municipalities tested positive to antibody 14 , and a smaller sample of 60 asymptomatic blood donors in one of the towns under lock-down showed 40 (66%) positive cases 15”
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis (2020, background): “According to a recent COVID-19 report from Italy, the surge in patients requiring intensive care has been unmanageable, with 12% of positive cases requiring ICU admission [49], more than that reported in China [18, 28].”
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy (2020, neutral): “The Spedali Civili of Brescia, a large university hospital with 1570 beds serving an area of nearly one million people in the east of Lombardy, is one of the 15 first-responder hub-hospitals admitting COVID19 patients [3].”
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. (2020, neutral): “/total (%) 5/498 (1) NA 0/15 0/42 2/149 (1) 3/193 (2) 0/95 0/4 NA”
- SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain (2020, neutral): “…rates have varied by more than 10-fold (Center for Systems Science and Engineering at Johns Hopkins University; COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention, 2020; Grasselli et al., 2020; Onder et al., 2020).”
- Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal (2020, neutral): “Titles, abstracts, and full texts were screened for eligibility in duplicate by independent reviewers (pairs from LW, BVC, MvS, and KGMM) using EPPI-Reviewer, 11 and discrepancies were resolved through discussion.”